Showing results (1671-1680 of 1,709) with videos related to

Sort By:
Pageof 171
Bioorganic & Medicinal Chemistry Letters|September 1, 2006
Potent, selective pyrimidinetrione-based inhibitors of MMP-13Lawrence A Reiter, Kevin D Freeman-Cook, Christopher S Jones, et al.
European Journal of Medicinal Chemistry|February 25, 2026
Development of a nucleotide prodrug of 4'-fluorouridine to improve tolerabilityAustin T Ryan, Jean-Marc I A Lawrence, Brett Virgin-Downey, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2020
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancerKyle G Mitchell, Behrang Amini, Yunfei Wang, et al.
British Journal of Cancer|June 22, 2013
Tumour morphology predicts PALB2 germline mutation statusZ L Teo, E Provenzano, G S Dite, et al.
Nature Communications|August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancerTina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.
Science (New York, N.Y.)|February 26, 2005
Dynamics of Saturn's magnetosphere from MIMI during Cassini's orbital insertionS M Krimigis, D G Mitchell, D C Hamilton, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13Kevin D Freeman-Cook, Lawrence A Reiter, Mark C Noe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2024
Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathiesMelissa R Perrino, Anirban Das, Sarah R Scollon, et al.
Annals of Surgical Oncology|February 19, 2026
Patient-Reported Symptom Recovery After Upper Gastrointestinal Cancer Surgery: A Prospective Study Using the MDASI-UGI-SurgKoichi Tomita, Paula M Smith, Maho Takayama, et al.
Pageof 171